Drug class review on proton pump inhibitors final report
Proton pump inhibitors (PPIs) decrease gastric acid and gastric secretory volume. PPIs are used to treat peptic ulcers (duodenal and gastric), symptoms of gastroesophageal reflux disease (GERD), erosive esophagitis, and drug-induced ulcers (e.g., non-steroidal anti-inflammatory drugs {NSAIDs}). The...
Main Author: | |
---|---|
Corporate Authors: | , |
Other Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Portland, Or.
Oregon Health & Science University, Evidence-Based Practice Center
2006, c2006
|
Series: | Drug class reviews
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | Proton pump inhibitors (PPIs) decrease gastric acid and gastric secretory volume. PPIs are used to treat peptic ulcers (duodenal and gastric), symptoms of gastroesophageal reflux disease (GERD), erosive esophagitis, and drug-induced ulcers (e.g., non-steroidal anti-inflammatory drugs {NSAIDs}). The purpose of this review is to compare the benefits and harms of different PPIs |
---|---|
Item Description: | "July 2006." |
Physical Description: | 1 PDF file (96 p.) ill |